Evidence for localization of biologically active recombinant retroviral vector to lymph nodes in mice injected intramuscularly

Gene Therapy

Volumn 3, Issue 2, 1996, Pages 128-136

  Kamantigue, E ^a   Edwards III, W ^a   Chada, S ^a   Brumm, D ^a   Austin, M ^a   Irwin, M ^a   Mento, S ^a   Kowal, K ^a   Sajjadi, N ^a  

^a Viagene Inc   (United States)

Author keywords

Cytotoxic T lymphocytes (CTL); Human immunodeficiency virus (HIV); Immunotherapeutic gene therapy; Polymerase chain reaction; Retroviral vector

Indexed keywords

FLUORESCEIN; LATEX; VIRUS DNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXPRESSION VECTOR; FEMALE; GENE TRANSFER; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPH NODE; MARKER GENE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROVIRUS; SPLEEN CELL; VIRUS RECOMBINANT;

ANIMALS; BASE SEQUENCE; DNA, RECOMBINANT; DNA, VIRAL; FEMALE; GENE TRANSFER TECHNIQUES; GENES, ENV; GENETIC VECTORS; HIV-1; INJECTIONS, INTRAMUSCULAR; LEUKEMIA VIRUS, MURINE; LYMPH NODES; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; MUSCLE, SKELETAL; POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, CYTOTOXIC;

ANIMALIA; DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; UNIDENTIFIED RETROVIRUS;

EID: 0029871824     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Sajjadi NC et al. Recombinant retroviral vector delivered intramuscularly localizes to the site of injection in mice. Hum Gene Ther 1994; 5: 693-699.
2. Temin HM. Retroviral vectors for gene transfer: efficient integration into and expression of exogenous DNA in vertebrate cell genomes. In: Kucherlapati R (ed). Gene Therapy. Plenum Press: New York, 1986, pp 149-187.
3. Anderson WF. Human gene marker/therapy clinical protocols. Hum Gene Ther 1994; 5: 1429.
4. Morgan RA, Anderson WF. Human gene therapy. Annu Rev Biochem 1993; 62: 191-217.
5. Morsy MA, Mitani K, Clemens P, Caskey T. Progress toward human gene therapy. JAMA 1993; 270: 2338-2345.
6. Jolly DJ. Viral vector systems for gene therapy. Cancer Gene Ther 1994; 1: 51-64.
7. Warner JF et al. Induction of HIV-specific CTL and antibody responses in mice using retroviral vector-transduced cells. AIDS Res Hum Retroviruses 1991: 7: 645-655.
8. Laube LS et al. Cytotoxic T lymphocyte (CTL) and antibody responses in rhesus monkeys immunized with retroviral vector transduced fibroblasts expressing HIV-1 IIIB Env/Rev proteins. Hum Gene Ther 1994; 5: 853-862.
9. Chada S et al. Cross-reactive lysis of human targets infected with prototypic and clinical human immunodeficiency virus type 1 (HIV-1) strains by murine anti-HTV-1 IIIB Env-specific cytotoxic T lymphocytes. J Virol 1993; 67: 3409-3417.
10. Irwin MJ et al. Direct injection of a recombinant retroviral vector induces human immunodeficiency virus-specific immune responses in mice and non-human primates. J Virol 1994; 68: 5036-5044.
11. Ziegner UHM et al. Cytotoxic T lymphocyte induction in asymptomatic HIV-1 infected patients immunized with Retrovector™-transduced autologous fibroblasts expressing HIV-1 IIIB Env/Rev proteins. AIDS 1995; 9: 43-50.
12. Nabel EG et al. Gene transfer in vivo with DNA-liposome complexes: lack of autoimmunity and gonadal localization. Hum Gen Ther 1992; 3: 649-656.
13. Temin HM. Safety considerations in somatic gene therapy of human disease with retrovirus vectors. Hum Gene Ther 1990; 1: 111-123.
14. Trono D. Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses. J Virol 1992; 68: 4893-4900.
15. Roe TY et al. Integration of murine leukemia virus DNA depends on mitosis. EMBO J 1993; 12: 2099-2108.
16. Rugh R. The Mouse. Oxford University Press: Oxford, 1990, p 29.
17. Blau HM, Dhawan J, Pavlath GK. Myoblasts in pattern formation and gene therapy. Trends Genet 1993; 9: 269-274.
18. Blau HM, Hughes SM. Retroviral lineage markers for assessing myoblast fate in vivo. Adv Exp Med Biol 1990; 280: 201-203.
19. Ando K et al. CTL access to tissue antigen is restricted in vivo. J Immunol 1994; 153: 482-488.
20. Barker CF, Billingham RE. Immunologically privileged sites. Adv Immunol 1977; 25: 1-54.
21. Niederhauser C et al. Reliability of PCR decontamination systems. PCR Meth Appl 1994; 4: 117-123.
22. Cone RW, Fairfax MR. Protocol for ultraviolet irradiation of surfaces to reduce PCR contamination. PCR Meth Appl 1993; 3: S15-S17.
23. Fox JC, Ait-Khaled M, Webster A, Emery VC. Eliminating PCR contamination: is UV irradiation the answer? J Virol Meth 1991; 33: 375-382.
24. Sarkar G, Sommer SS. Parameters affecting susceptibility of PCR contamination to UV inactivation. Biotechniques 1991; 10: 590-594.
25. Ou CY et al. DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells. Science 1988; 239: 295-297.
26. Clouse KA et al. Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell done. J Immunol 1989; 142: 431-438.